SIRT1 is also able to deacetylate Ku70, which activates the protein [96], and higher expression of SIRT1 has been observed in CML and AML patients [97]. This evidence concerns the gene SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive.